Editors Choice

Will Blood Glucose Become The New Blood Pressure?

It is possible that tracking blood sugar levels could become a more commonly used metric in healthcare, similar to how blood pressure is used to track patients’ health?  Recently, news from Apple suggests that watch-based blood glucose measurement is in “the proof of concept stage.”

Blood sugar levels are already routinely monitored in patients with diabetes or those at risk of developing diabetes, but the importance of maintaining stable blood sugar levels for overall health is becoming more widely recognized. Elevated blood sugar levels, even if not high enough to indicate diabetes, may be associated with an increased risk of cardiovascular disease, kidney disease, and other health problems.

As a result, tracking blood sugar levels without diabetes or pre-diabetes may become a tool for managing both disease and wellness. Or perhaps, availability of broader data sets can foster research examine blood glucose levels and trajectory to offer new insights into the pathophysiology of related diseases at earlier points in time.

Digital health has often offered monitoring solutions that reside in the consumers hands (or wrists). And this has certainly been a mixed blessing.  Some tools have provided valuable insights into health.  Yet some have become merely a source of arbitrary information that cannot be translated into clinical value.  Further, this added burden to healthcare providers may further preclude adoption.  But as innovation has taught us, the next big thing can often be close at hand.  The emergence of continuous blood glucose monitoring (CGM) has been transformative for patients.  And the new data sets have given scientists powerful insights into glucose kinetics and insulin administration.   And these insights maybe game-changing with the global concerns of obesity and metabolic syndrome.

Your watch is becoming a value tool in wellness and disease management.  And that value is only beginning to be realized and implemented.

John Nosta

John is the founder of NostaLab, a digital health think tank recognized globally for an inspired vision of digital transformation. His focus is on guiding companies, NGOs, and governments through the dynamics of exponential change and the diffusion of innovation into complex systems. He is also a member of the Google Health Advisory Board and the WHO’s Digital Health Roster of Experts. He is a frequent and popular contributor to Fortune, Forbes, Psychology Today and Bloomberg as well as prestigious peer-reviewed journals including The American Journal of Physiology, Circulation, and The American Journal of Hematology.

Recent Posts

Science Has No Borders – And Neither Should Human Potential

Here at the HIMSS AI in Healthcare Forum, held in Brooklyn—long a gateway for immigration…

2 days ago

The Stroke That Stole My Father And the Tiny Device That Could Stop the Next One

It happened without warning. My father collapsed at home, his face slack, his words gone.…

2 days ago

Why AI’s Future in the Health Sector Hinges on Leadership, Not Just Technology

The room was standing room only. At the HIMSS AI in Healthcare Forum, the energy…

2 days ago

Pandora’s Ghost: The Seduction of Artificial Perfection

We didn’t open the box out of malice. We opened it because we were curious.…

3 days ago

Can Doctors “Gaslight” Their Patients?

I was taken aback by the term used in the article published in JAMA Network…

4 days ago

Clinic Notes: She Taught Me Stillness

She sat across from me in the radiation oncology exam room, hands folded in her…

5 days ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More